Close
Help





JOURNAL

Drug Target Insights


Submit a Paper




Call for Papers

The Editor in Chief, Professor Anuj Chauhan (University of Florida), welcomes new manuscripts for peer review on the following topics including but not limited to :

  • Current developments in all areas of the field of clinical therapeutics
  • Molecular drug targets including: disease-specific proteins, receptors, enzymes, and genes
  • Impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life


Open Special Collections

We are also accepting submissions for the following Special Collections. If any of these are the right fit for your research, we would be happy to receive your paper for peer review. Please enter the Promo Code listed next to each collection below during Step 2 of the submission process to indicate your interest in publishing in this Special Collection.

  • Current Developments in Drug Delivery by Nanoparticles; Promo code to submit: DTI-12
  • Current Developments in Targeted Cancer Therapy; Promo code to submit: DTI-11b, DTI- 11c
  • Drug, Protein and Gene Delivery by Nanoparticles; Promo code to submit: DT1-10

All papers accepted into these Special Collections will benefit from a reduced Article Processing Charge (APC) of $750 (£500 GBP), discounted from the full rate for a limited time.


Become a Guest Editor for a Special Collection

We are also interested in publishing further special collections. If you are interested in leading a special collection as a Guest Editor, please submit a proposal here.

Further information on the role can be found in the Lead Guest Editor Guide.


Benefits of Publishing
 

The journal offers significant benefits to authors including:

  • International, peer-reviewed open access journal
  • Listed on PubMed and freely available via PubMed Central
  • Indexed in: Web of Science Emerging Sources Citation Index (ESCI), Directory of Open Access Journals (DOAJ) and Scopus
  • Fast, rigorous peer review
  • Open access format, driving high visibility and global exposure
  • Article metrics service to allow each author to monitor re-use of published articles

Manuscripts submitted to the journal are subject to double-blind peer review by a minimum of two to three suitably qualified reviewers. All editorial decisions are the responsibility of Editor-in-Chief, Deputy Editor-in-Chief, or an Associate Editor. Each stage of the editorial and production process is monitored to prevent delays to the authors, who are regularly informed of changes in their paper's status. Editorial contributors, journal staff, and external contractors who contribute to editorial and production processes are qualified, experienced professionals chosen for their ability to efficiently contribute towards high-quality published papers. Article processing charges are communicated to authors prior to and during manuscript submission. There are no additional fees based on use of color, figure or word-count.


Further Information



  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors

Quick Links


New article and journal news notification services